Evidence map›Paper›PMID 36432430›Full record

ArticleNutrients2022

Effects of Enzamin, a Microbial Product, on Alterations of Intestinal Microbiota Induced by a High-Fat Diet.

Toshinori Yasuzawa, Ryota Nishi, Satono Ishitani, Osamu Matsuo, Shigeru Ueshima

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Frontiers in microbiology · 2025
    Article
  2. Advancing sustainable practices withAIMS microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Toshinori YasuzawaDepartment of Nutrition, School of Human Cultures, The University of Shiga Prefecture, Hikone 522-8533, Japan.ORCID 0000-0002-6169-2667
Ryota NishiDepartment of Food Science and Nutrition, Faculty of Agriculture, Kindai University, Nara 631-8505, Japan.
Satono IshitaniDepartment of Food Science and Nutrition, Faculty of Agriculture, Kindai University, Nara 631-8505, Japan.
Osamu MatsuoFaculty of Medicine, Kindai University, Osaka-Sayama 589-9511, Japan.
Shigeru UeshimaDepartment of Food Science and Nutrition, Faculty of Agriculture, Kindai University, Nara 631-8505, Japan.
Kindai University · JPUniversity of Shiga Prefecture · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the human intestinal tract, there are more than 100 trillion microorganisms classified into at least 1000 different species. The intestinal microbiota contributes to the regulation of systemic physiologic functions and the maintenance of homeostasis of the host. It has been reported that the alteration of the intestinal microbiota is involved in metabolic syndromes, including type II diabetes and dyslipidemia, inflammatory bowel disease, allergic disease, and cancer growth. It has been reported that a microbial product from

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeAnimalsDiet, High-FatHumansInflammationLipopolysaccharidesMiceMice, ObeseLipopolysaccharidesadhesion moleculeEnzamininflammationintestinal microbiota

Identifiers

PMID36432430
PMCPMC9694229
OpenAlexW4308865912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.